Annual report pursuant to Section 13 and 15(d)

Schedule of Segment Information (Details)

v3.22.1
Schedule of Segment Information (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Segment Reporting Information [Line Items]    
Revenues, net $ 79,042 $ 14,514
Consolidated cost of revenue 37,054 9,908
Total Depreciation and amortization expense 1,983 126
Operating and other expenses 34,700 6,818
Total income (loss) from continuing operations, after income taxes 6,273 (2,326)
Total income (loss) from continuing operations, before income taxes 5,305 (2,314)
Income tax benefit (expense) 968 (12)
Income from discontinued operations, before income taxes 201
Net income (loss) 6,273 (2,125)
Total assets 89,295 31,405
Diagnostic Services [Member]    
Segment Reporting Information [Line Items]    
Revenues, net 68,559 1,277
Consolidated cost of revenue 29,415 644
Total Depreciation and amortization expense 1,976 37
Total income (loss) from continuing operations, after income taxes 18,197 (270)
Total assets 51,150 13,410
Consumer Products [Member]    
Segment Reporting Information [Line Items]    
Revenues, net 10,483 13,237
Consolidated cost of revenue 7,639 9,264
Total Depreciation and amortization expense 7 89
Total income (loss) from continuing operations, after income taxes (1,714) 1,962
Total assets 24,139 6,261
Unallocated Corporate [Member]    
Segment Reporting Information [Line Items]    
Total income (loss) from continuing operations, after income taxes (11,178) (4,006)
Total assets $ 14,006 $ 11,734